Combined Use of Multiple Biomarkers With Stress Testing to Detect Coronary Artery Disease
NCT ID: NCT03137550
Last Updated: 2022-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
850 participants
OBSERVATIONAL
2017-04-12
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis of our study is that diagnosis of CAD can be improved by adding biomarkers to solely stress testing for the workup of patients with suspected CAD or progress of already known CAD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers in Acute Cardiac Care
NCT02355457
Ruling Out Coronary Artery Disease and Myocardial Injury by Biomarkers
NCT04144725
Dual Source CT Angiography for Detection of Coronary Artery Stenoses
NCT01190579
Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease
NCT04009421
Exercise-induced High-sensitivity Troponin Levels as a Predictor for Obstructive Coronary Artery Disease
NCT02626806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Physical or psychological incapability to take part in the investigation
3. Persons with no sufficient language ability in German to understand the provided study information material.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Hamburg-Eppendorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefan Blankenberg, MD
Role: PRINCIPAL_INVESTIGATOR
Head of the Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of General and Interventional Cardiology, University Heart Center Hamburg
Hamburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PV4023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.